Free Trial

Aura Biosciences (AURA) Competitors

Aura Biosciences logo
$6.32 +0.16 (+2.58%)
Closing price 03:59 PM Eastern
Extended Trading
$6.33 +0.01 (+0.17%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AURA vs. SDGR, HROW, SNDX, EVO, ZYME, AVDL, TSHA, ORIC, SION, and XERS

Should you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Schrodinger (SDGR), Harrow (HROW), Syndax Pharmaceuticals (SNDX), Evotec (EVO), Zymeworks (ZYME), Avadel Pharmaceuticals (AVDL), Taysha Gene Therapies (TSHA), Oric Pharmaceuticals (ORIC), Sionna Therapeutics (SION), and Xeris Biopharma (XERS). These companies are all part of the "pharmaceutical products" industry.

Aura Biosciences vs. Its Competitors

Aura Biosciences (NASDAQ:AURA) and Schrodinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

96.8% of Aura Biosciences shares are owned by institutional investors. Comparatively, 79.1% of Schrodinger shares are owned by institutional investors. 6.3% of Aura Biosciences shares are owned by insiders. Comparatively, 21.0% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Aura Biosciences and Aura Biosciences both had 4 articles in the media. Aura Biosciences' average media sentiment score of 0.81 beat Schrodinger's score of 0.36 indicating that Aura Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aura Biosciences
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Schrodinger
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aura Biosciences presently has a consensus target price of $22.00, indicating a potential upside of 248.16%. Schrodinger has a consensus target price of $26.29, indicating a potential upside of 27.52%. Given Aura Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Aura Biosciences is more favorable than Schrodinger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aura Biosciences
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78
Schrodinger
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

Aura Biosciences has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500.

Aura Biosciences has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aura BiosciencesN/AN/A-$86.92M-$1.96-3.22
Schrodinger$207.54M7.31-$187.12M-$2.48-8.31

Aura Biosciences has a net margin of 0.00% compared to Schrodinger's net margin of -76.22%. Schrodinger's return on equity of -45.70% beat Aura Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Aura BiosciencesN/A -64.44% -54.24%
Schrodinger -76.22%-45.70%-24.81%

Summary

Aura Biosciences beats Schrodinger on 10 of the 15 factors compared between the two stocks.

Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AURA vs. The Competition

MetricAura BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$392.54M$3.39B$6.04B$10.49B
Dividend YieldN/A2.30%5.73%4.80%
P/E Ratio-3.2222.9085.1927.32
Price / SalesN/A269.18516.16194.55
Price / CashN/A46.9537.5761.53
Price / Book2.0810.5312.426.81
Net Income-$86.92M-$52.58M$3.32B$276.59M
7 Day Performance3.76%1.06%0.80%0.15%
1 Month Performance5.85%16.05%10.52%8.17%
1 Year Performance-35.91%18.41%76.14%35.50%

Aura Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AURA
Aura Biosciences
1.9856 of 5 stars
$6.32
+2.6%
$22.00
+248.2%
-34.0%$392.54MN/A-3.2250High Trading Volume
SDGR
Schrodinger
2.6422 of 5 stars
$19.70
+3.2%
$26.29
+33.4%
+9.0%$1.40B$207.54M-7.94790Analyst Forecast
HROW
Harrow
2.7602 of 5 stars
$38.77
+3.4%
$68.50
+76.7%
-22.7%$1.39B$199.61M-155.08180
SNDX
Syndax Pharmaceuticals
3.6399 of 5 stars
$15.20
-5.4%
$39.22
+158.0%
-22.8%$1.38B$23.68M-3.91110
EVO
Evotec
2.0058 of 5 stars
$3.95
+2.1%
$7.00
+77.2%
+31.1%$1.37B$862.40M0.004,827
ZYME
Zymeworks
2.3156 of 5 stars
$18.11
+0.3%
$22.50
+24.2%
+37.1%$1.36B$122.87M-12.07460News Coverage
Analyst Forecast
AVDL
Avadel Pharmaceuticals
2.7138 of 5 stars
$14.20
+1.4%
$20.86
+46.9%
+9.1%$1.36B$169.12M-473.3370
TSHA
Taysha Gene Therapies
2.4035 of 5 stars
$5.05
+3.5%
$9.00
+78.2%
+159.3%$1.33B$8.33M-14.85180Gap Up
ORIC
Oric Pharmaceuticals
4.2939 of 5 stars
$13.91
+1.7%
$17.29
+24.3%
+37.9%$1.33BN/A-7.3680Gap Up
SION
Sionna Therapeutics
2.7158 of 5 stars
$29.31
-0.4%
$38.00
+29.6%
N/A$1.30BN/A0.0035
XERS
Xeris Biopharma
2.983 of 5 stars
$7.95
-0.5%
$7.08
-10.9%
+173.4%$1.29B$203.07M-37.86290News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:AURA) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners